Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome

Kidney International

Volumn 45, Issue 5, 1994, Pages 1446-1456

  Meyrier, Alain ^b   Noël, Laure Helene ^a   Auriche, Pascal ^a   Callard, Patrice ^a   Meyrier, A ^a   Pollini, J ^a   Mac Namara, E ^a   Bourbigot, B ^a   Cledes, J ^a   Tanneau, R ^a   Ryckelynck, J P ^a   Freida, P ^a   Potier, J ^a   Tolani, M ^a   Kourilsky, O ^a   Haultier, J J ^a   Leski, M ^a   Maurizi, J ^a   Zaoui, P ^a   Babinet, F ^a   Lebon, P ^a   Francois B ^a   Cahen, R ^a   Duhoux, P ^a   Olmer, M ^a   Kleinknecht, D ^a   Guenel, J ^a   Cassuto Viguier, E ^a   Gardin, J C ^a   Paillard, M ^a   Tual, J L ^a   Lesavre, P ^a   Touchard, G ^a   Melin, J P ^a   Moulin, B ^a   Fillastre, J P ^a   Simon, P ^a   Berthoux, F ^a   Birmele B ^a   Nivet, H ^a   Montagnac, R ^a   Schillinger, F ^a   Coville, P ^a   more..

^a Hôpital Avicenne ^*

^b AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG THERAPY; DRUG TOLERANCE; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; IDIOPATHIC DISEASE; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0028212949     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1994.189     Document Type: Article

References (36)

1. TEJANI A: Morphological transition in minimal change nephrotic syndrome. Nephron 39:157-159, 1985
2. CAMERON JS: The nephrotic syndrome and its complications. Am J Kidney Dis 10:157-71, 1987
3. MELVIN T, BENNETT W: Management of nephrotic syndrome in childhood. Drugs 42:30-51, 1991
4. MEYRIER A, SIMON P: Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: Minimal change disease and focal segmental glomerulosclerosis. Adv Nephrol 17:127-150, 1988
5. PEI Y, CATTRAN D, DELMORE T, KATZ A, LANG A, RANGE P: Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional glomerulonephritis registry study. Am J Med 82:938-944, 1987
6. NOLASCO F, CAMERON JS, HEYWOOD EF, HICKS J, OGG C, WILLIAMS DG: Adult-onset minimal change nephrotic syndrome: A long-term follow-up. Kidney Int 29:1215-1223, 1986
7. KORBET SM, SCHWARTZ MM, LEWIS EJ: The prognosis of focal segmental glomerular sclerosis of adulthood. Medicine 65:304-311, 1986
8. BROYER M, MEYRIER A, NIAUDET P, HABIB R: Minimal changes and focal segmental glomerulosclerosis, in Oxford Textbook of Clinical Nephrology, edited by CAMERON S, DAVISON AM, GRÜNFELD JP, KERR D, RITZ E, Oxford, Oxford University Press, 1992, pp. 298-339
9. CAMERON JS: Treatment of primary glomerulonephritis using immunosuppressive agents. Am J Nephrol 9 (Suppl 1):33-40, 1989
10. PONTICELLI C, PASSERINI P: Alkylating agents and purine analogues in primary glomerulonephritis with nephrotic syndrome. Nephrol Dial Transplant 6:381-388, 1991
11. MEYRIER A: Treatment of glomerular disease with cyclosporin A. Nephrol Dial Transplant 4:923-931, 1989
12. MEYRIER A, COLLABORATIVE GROUP OF THE SOCIÉTÉ DE NÉPHROLOGIE: Cyclosporin in steroid-resistant nephrosis. Am J Nephrol 9 (Suppl):65-71, 1989
13. CYCLOSPORIN A (SANDIMMUN) IN NEPHROTIC SYNDROME. Clin Nephrol, edited by PONTICELLI C: 35 (Suppl 1):3-62, 1991
14. MYERS BD, ROSS J, NEWTON L, LÜTSCHER J, PERLROTH A: Cyclosporin-associated chronic nephropathy. N Engl J Med 331: 699-705, 1984
15. PALESTINE AG, AUSTIN HA, BALOW JE, ANTONOVYCH TT, SABNIS GS, PREUSS HG, NUSSENBLATT RB: Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med 314:1293-1298, 1986
16. PUSCHETT JB, GREENBERG A, HOLLEY J, MCCAULEY J: The spectrum of cyclosporin nephrotoxicity. Am J Nephrol 10:296-309, 1990
17. FEUTREN G, MIHATSCH MJ: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 326:1654-1660, 1992
18. PONTICELLI C, RIZZONI G, EDEFONTI A, ALTIERI P, RIVOLTA E, RINALDI S, GHIO L, LUSVARGHI E, GUSMANO R, LOCATELLI F, PASQUALI S, CASTELLANI A, DELLA CASA-ALBERIGHI O: A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43:1377-1384, 1993
19. NIAUDET P, BROYER M, HABIB R: Evaluation of nephrotoxicity by sequential biopsies in 38 children with idiopathic nephrosis treated with cyclosporin A (CsA). (abstract) Kidney Int 37:260, 1990
20. NIAUDET P, BROYER M, HABIB R: Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. Clin Nephrol 35 (Suppl 1):S31-S36, 1991
21. MEYRIER A, CONDAMIN MC, BRONEER D, THE COLLABORATIVE GROUP OF THE FRENCH SOCIETY OF NEPHROLOGY: Treatment of adult idiopathic nephrotic syndrome with cyclosporine A: Minimal-change disease and focal-segmental glomerulosclerosis. Clin Nephrol 35(Suppl 1):S37-S42, 1991
22. MEYRIER A, COLLABORATIVE GROUP OF THE SOCIÉTÉ DE NÉPHROLOGIE: Long-term tolerance of cyclosporine A (CsA) treatment in nephrosis. (abstract) Kidney Int 35:197, 1989
23. MEYRIER A, NOEL LH, COLLABORATIVE GROUP OF THE SOCIÉTÉ DE NÉPHROLOGIE: Long-term tolerance of cyclosporine A treatment in adult nephrosis. A study based on repeat biopsies. (abstract) Proceedings of the XIIth International Congress of Nephrology, Jerusalem, June 13-18, 1993, p. 537
24. FUJIMOTO S, YAMAMOTO Y, HISANAGA S, MORITA S, ETO T, TANAKA K: Minimal change nephrotic syndrome in adults: Response to corticosteroid therapy and frequency of relapse. Am J Kidney Dis 17:687-692, 1991
25. MIHATSCH MJ, THIEL G, RYFFEL B: Cyclosporine nephrotoxicity. Adv Nephrol 17:303-320, 1988
26. WINGEN AM, MEHLS O, RUDER H, ROSENDAHL W, SCHERRER K: Evidence for acceleration of progression of renal failure by cyclosporin A in children with steroid-resistant nephrotic syndrome. (abstract) Nephrol Dial Transplant 4:432, 1989
27. PEI Y, SCHOLEY J, KATZ A, ZALTMAN J, CATTRAN D, SCHACHTER R, KRIGER F: Renal structures and function in psoriatic patients treated with chronic low-dose cyclosporine. (abstract) J Am Soc Nephrol 2:241, 1991
28. RICH A: A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 100:173-186, 1957
29. HEPTINSTALL RH: The Nephrotic Syndrome, in Pathology of the Kidney (3rd ed vol II), edited by HEPTINSTALL RH, Boston, Little Brown, 1983, p. 678
30. COLLABORATIVE GROUP OF THE SOCIÉTÉ DE NÉPHROLOGIE: Adult steroid-resistant nephrotic FSGS is not an indication for CsA treatment. (abstract) J Am Soc Nephrol 1:311, 1990
31. KOHAUT EC, EDWARDS GA, LEIGHTON HILL L, ROSENBERG HS, HARTLEY MW: Focal glomerulosclerosis. Extent of involvement related to steroid resistance. Am J Clin Pathol 75:181-185, 1981
32. CAMERON JS: Immunologically mediated interstitial nephritis: Primary and secondary. Adv Nephrol 18:207-248, 1989
33. ITTEL TH, SCHMITT H, MROWKA C, SIEBERTH HG: Cyclosporine long-term treatment of minimal change nephrotic syndrome (MCNS) with cyclosporine A: Is there a loss of efficacy? (abstract) J Am Soc Nephrol, 4:278, 1993
34. MURPHY FD, WARFIELD LM, GRILL J, ANNIS ER: Lipoid nephrosis. A study of nine patients, with special reference to those observed over a long period. Arch Intern Med 62:355-376, 1938
35. BARNESS LA, MOLL GH, JANEWAY CA: Nephrotic syndrome, natural history of the disease. Pediatrics 5:486-493, 1950
36. ARNEIL GC, LAM CN: Long-term assessment of steroid therapy in childhood nephrosis. Lancet ii:819-821, 1966